Skip to main content
Caplight Logo









Inventis

Inventis

Private
ItalyHealthcare & Life Scienceshttps://inventis.it/en-na

Last Round

VC Round

Nov 9, 2018

Company Overview

Inventis operates in Healthcare & Life Sciences and is based in Italy. Its latest recorded funding round was a VC Round in November 2018.

Inventis is a medical technology company that develops and manufactures diagnostic equipment for audiology and balance assessment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Inventis Comparables

Compare Inventis with similar companies based on industry and business-model similarity.

Inventis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PATH medical GmbH
86%
Natus Medical Incorporated
82%
Otodynamics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Inventis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 9, 2018
GrantOct 8, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Luca Bressan

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Inventis Investors

Notable investors and investment history

Inventis investors
InvestorRounds
Regione del VenetoGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 33% MoM, reaching 14.1K.

  • Nov 7, 2025

    Monthly visitors grew 129% MoM, reaching 19.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Inventis Filings

Explore SEC and related filing metadata, where available.

Inventis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Inventis's valuation, stock price, and market status.

Is Inventis a public or private company?

Inventis is a private company.

What is the current stock price of Inventis?

Inventis is a private company, so its shares have no public market price. Caplight tracks Inventis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Inventis worth (valuation)?

Valuation information for Inventis is not publicly available.

Can I buy Inventis stock?

Inventis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Inventis's last funding round?

Inventis's most recent funding round was VC Round on November 9, 2018.

Who are the main investors in Inventis?

Key investors in Inventis include Regione del Veneto.

Will Inventis IPO soon?

No public IPO plans have been announced for Inventis.

How can I track Inventis secondary market activity?

Caplight tracks bids, offers, and trades in Inventis's shares on secondary markets.

Firmographic Details

HeadquartersItaly
Employee Range78
Year Founded2005
Last FundingNov 9, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?